Kaimax 100U – Premium Korean Botulinum Toxin Type A
Manufactured by JETEMA Co. under cGMP standards (FDA/EMA certified), Kaimax 100U contains 99.8% pure neurotoxin derived from the original European CBFC26 strain. Clinically proven to reduce dynamic wrinkles within 5-14 days with 4-month duration. Ideal for glabellar lines, crow’s feet, and masseter hypertrophy treatment.
Key Clinical Advantages
✔︎ 99.8% toxin purity
✔︎ <0.5ng protein/vial
✔︎ 5-14 day onset
✔︎ 120-day efficacy
✔︎ Low antigenicity
✔︎ cGMP certified
✔︎ 36-month stability
✔︎ 0 adverse reports
Advanced Stabilization Technology
Utilizing lyophilized albumin matrix with USP-grade sodium chloride (0.9mg), our proprietary formulation maintains 95% biological activity after 3-year refrigeration (2-8°C). The CBFC26 strain produces 150kDa neurotoxin particles optimized for precise neuromuscular targeting.
Pharmaceutical Specifications
• 1 vial = 100 units (mouse LD50 units)
• 0.5mg HSA/vial (EP grade)
• pH 6.8-7.4 after reconstitution
• ≤0.03EU endotoxin/vial
Clinical Protocol
1. Reconstitute with 0.9% saline (2.5ml/100U)
2. Gentle swirling only – no vortexing
3. Use within 24hrs (2-8°C storage)
4. 0.1ml injection volume per site
⚠ Maximum 50U per treatment area
*Prescription medical device. For certified practitioners only. Not for generalized spasticity. Avoid use in pregnancy. Clinical outcomes may vary based on injection technique and patient physiology. Always follow local regulatory guidelines.
Reviews
There are no reviews yet.